Neural Bases of Post-stroke Emotion Perception Disorders
Launched by UNIVERSITY HOSPITAL, LILLE · Oct 21, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a stroke affects the way people recognize emotions in others. Researchers want to understand the brain processes involved in this by comparing stroke patients to healthy individuals using advanced imaging techniques like MRI and EEG. The goal is to learn more about the emotional challenges that stroke survivors may face.
To participate, stroke patients must be between 18 and 80 years old, have experienced a stroke (either from a blockage or bleeding in the brain) at least six months prior, and be able to give consent. Healthy participants should also be between 18 and 80 but must not have any history of neurological or psychiatric conditions. Participants can expect to undergo some tests that involve brain imaging and answering questions about their emotional health. It's important to know that the study is not yet recruiting, so interested individuals will need to wait until it begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Stroke group:
- • Man or Woman
- • Age 18-80y
- • Unique stroke, ischemic or hemorrhagic
- • at the chronic phase (\< 6 months)
- • Written informed consent
- • subject having a social insurance
- • Subject who consent to complete all the study's experiments
- Healthy controls group:
- • Man or Woman
- • Age 18-80y
- • No history of neurological or psychiatric disease.
- Exclusion Criteria:
- • Stroke group
- • Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
- • History of other neurologic disorders
- • Significant le vel of depression or anxiety, assessed by the STAI and the BDI questionnaires
- • Non corrected visual loss
- • Subjects suffering from visual neglect (assessed by the Bells Test and a bisection test (20mm)
- • contra-indications to MRI
- • pregnant or breastfeeding woman
- • Women of childbearing age without effective contraception
- • Healthy controls group
- • Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
- • History of neurologic disorders
- • Significant level of depression or anxiety, assessed by the STAI and the BDI questionnaires
- • Non-corrected visual loss
- • contra-indications to MRI
- • pregnant or breastfeeding woman
- • Women of childbearing age without effective contraception
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Etienne Allart, MD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials